American Century Companies Inc. Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

American Century Companies Inc. lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 10.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,798,270 shares of the company's stock after selling 551,075 shares during the quarter. American Century Companies Inc. owned approximately 3.85% of Henry Schein worth $332,040,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Versant Capital Management Inc boosted its holdings in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC increased its holdings in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock valued at $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC raised its position in Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the last quarter. Smartleaf Asset Management LLC lifted its holdings in Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock worth $52,000 after buying an additional 143 shares in the last quarter. Finally, City State Bank bought a new position in Henry Schein in the 4th quarter valued at $55,000. Institutional investors and hedge funds own 96.62% of the company's stock.

Remove Ads

Henry Schein Price Performance

HSIC stock traded up $0.37 during midday trading on Wednesday, reaching $69.75. The company had a trading volume of 922,231 shares, compared to its average volume of 1,506,094. The company has a market capitalization of $8.66 billion, a price-to-earnings ratio of 28.70, a price-to-earnings-growth ratio of 2.13 and a beta of 0.90. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.49. The stock has a 50 day moving average price of $74.76 and a 200-day moving average price of $72.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the business earned $0.66 earnings per share. Equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Insider Transactions at Henry Schein

In related news, CEO Bradford C. Connett sold 4,036 shares of the company's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the transaction, the director now directly owns 24,805 shares in the company, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HSIC shares. Mizuho started coverage on Henry Schein in a report on Wednesday, December 4th. They issued a "neutral" rating and a $75.00 price target on the stock. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective on the stock. Finally, Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and lifted their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.